K-lyte Ds Generic Name & Formulations
Potassium (as bicarbonate and citrate) 50mEq; effervescent tabs for soln; lime and orange flavor.
K-Lyte—30, 100, 250; DS—30, 100
K-lyte Ds Indications
Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.
K-lyte Ds Dosage and Administration
Prophylaxis: 25mEq daily. Treatment: 50–100mEq daily in divided doses. Both, dissolve each tab in 4–8oz of water and sip slowly over 5–10 minutes after meals.
K-lyte Ds Contraindications
Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility.
K-lyte Ds Boxed Warnings
K-lyte Ds Warnings/Precautions
Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.
K-lyte Ds Pharmacokinetics
K-lyte Ds Interactions
Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.
K-lyte Ds Adverse Reactions
Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation.
K-lyte Ds Clinical Trials
K-lyte Ds Note
K-lyte Ds Patient Counseling